More evidence is required for short-term treatment of exacerbations of chronic obstructive pulmonary disease: 3 days or no antibiotic at all? [2]

Clinical Microbiology and Infection

Volumn 13, Issue 7, 2007, Pages 748-749

  Llor, Carles ^a   Miravitlles, M ^b  

^a Primary Care Centre Jaume I   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; GEMIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AIRWAY OBSTRUCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE EXACERBATION; DISEASE SEVERITY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG INDICATION; EVIDENCE BASED MEDICINE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HUMAN; LETTER; LOWER RESPIRATORY TRACT INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; SAMPLE SIZE; SHORT COURSE THERAPY; TREATMENT DURATION;

EID: 34250305973     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01754.x     Document Type: Letter

References (10)

1. Roede BM, El Moussaoui R, Krouwels FH et al. Three vs. 10 days of amoxycillin-clavulanic acid for type 1 acute exacerbations of chronic obstructive pulmonary disease: A randomised, double-blind study. Clin Microbiol Infect 2007; 13: 284-290.
2. El Moussaoui R, de Borgie CA, van den Broek P et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: Randomized, double blind study. BMJ 2006; 332: 1355-1362.
3. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
4. Balser E, Neher JO, Safranek S. When are antibiotics indicated for acute COPD exacerbations? J Fam Pract 2006; 55: 1079-1080.
5. Wilson R, Schentag JJ, Ball P, Mandell L. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchtis and long-term clinical outcomes. Clin Ther 2002; 24: 639-652.
6. Miravitlles M, Llor C, Naberan K, Cots JM, Molina J. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Respir Med 2005; 99: 955-965.
7. Martinez FJ, Grossman RF, Zadeikis N et al. Patient stratification in the management of acute bacterial exacerbation of chronic bronchitis: the role of levofloxacin 750 mg. Eur Respir J 2005; 25: 1001-1010.
8. Little P, Rumsby K, Kelly J et al. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: A randomized controlled trial. JAMA 2005; 293: 3029-3035.
9. Wilkinson TMA, Donaldson GC, Hurst JR, Seemungal TAR, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298-1303.
10. Spurling GK, Del Mar CB, Dooley L, Foxlee R. Delayed antibiotics for symptoms and complications of respiratory infections. Cochrane Database Syst Rev 2004; 4: CD004417.